InvestorsHub Logo
Followers 32
Posts 3559
Boards Moderated 0
Alias Born 07/02/2004

Re: None

Monday, 04/28/2014 6:18:17 AM

Monday, April 28, 2014 6:18:17 AM

Post# of 97239
NEPT $2.23- Neptune and Enzymotec settle their patent infringement dispute.

http://finance.yahoo.com/news/neptune-enzymotec-conclude-final-patent-003237238.html

"This successfully brings to a conclusion all of the outstanding litigation issues before the ITC, with Neptune concluding favourable agreements with all ten Respondents named in the investigation," highlighted Mr. Benoît Huart, Director Legal Affairs of Neptune. "Consequently, Neptune has now licensed some of its patents to all of the major players in the worldwide krill oil industry. In addition, these settlements preserve strong IP protection for both Neptune and Acasti, allowing them to defend their respective markets."

I anticipate news about NEPT's new krill oil plant becoming operational will be released in the very near future.

NEPT stock is currently trading a few ticks off its 52 week low

Additional info about its 49.95% owned subsidiary Acasti can be found here:

http://seekingalpha.com/article/2119933-acasti-pharma-an-undervalued-biotech-with-a-potential-best-in-class-omegaminus-3-drug

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.